Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1993 1
1997 3
1999 1
2012 1
2013 3
2014 3
2015 1
2016 1
2017 6
2018 7
2019 5
2020 3
2021 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ishiko hr
Search for Isiko HR instead (1 results)
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Heerspink HJL, Parving HH, Andress DL, Bakris G, Correa-Rotter R, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray JJV, Melnick JZ, Miller MG, Pergola PE, Perkovic V, Tobe S, Yi T, Wigderson M, de Zeeuw D; SONAR Committees and Investigators. Heerspink HJL, et al. Lancet. 2019 May 11;393(10184):1937-1947. doi: 10.1016/S0140-6736(19)30772-X. Epub 2019 Apr 14. Lancet. 2019. PMID: 30995972 Clinical Trial.
Median follow-up was 2.2 years (IQR 1.4-2.9). 79 (6.0%) of 1325 patients in the atrasentan group and 105 (7.9%) of 1323 in the placebo group had a primary composite renal endpoint event (hazard ratio [HR] 0.65 [95% CI 0.49-0.88]; p=0.0047). Fluid retention and anaemia adve …
Median follow-up was 2.2 years (IQR 1.4-2.9). 79 (6.0%) of 1325 patients in the atrasentan group and 105 (7.9%) of 1323 in the placebo group …
Genotype and X-chromosome inactivation are associated with disease severity in females with X-linked Alport syndrome.
Suzuki R, Sakakibara N, Murakami S, Ichikawa Y, Kitakado H, Ueda C, Tanaka Y, Okada E, Kondo A, Aoto Y, Ishiko S, Ishimori S, Nagano C, Yamamura T, Horinouchi T, Okamoto T, Nozu K. Suzuki R, et al. Nephrol Dial Transplant. 2025 Apr 1;40(4):688-695. doi: 10.1093/ndt/gfae182. Nephrol Dial Transplant. 2025. PMID: 39134512
In paediatric female patients, both genotype and XCI pattern were significant independent risk factors for the development of proteinuria {hazard ratio [HR] 3.702 [95% confidence interval (CI) 1.681-8.150], P = .001 and HR 1.043 [95% CI 1.061-1.070], P = .001, respe …
In paediatric female patients, both genotype and XCI pattern were significant independent risk factors for the development of proteinuria {h …
The Number of Positive Tumor Marker Status Is Beneficial for the Selection of Therapeutic Modalities in Patients with Hepatocellular Carcinoma.
Beppu T, Nakagawa S, Nitta H, Okabe H, Kaida T, Imai K, Hayashi H, Koga Y, Kuramoto K, Hashimoto D, Yamashita YI, Chikamoto A, Ishiko T, Baba H. Beppu T, et al. J Clin Transl Hepatol. 2017 Jun 28;5(2):165-168. doi: 10.14218/JCTH.2016.00055. Epub 2017 May 10. J Clin Transl Hepatol. 2017. PMID: 28660154 Free PMC article. Review.
Hepatic resection (HR) and radiofrequency ablation (RFA) are popular local therapies for early-stage hepatocellular carcinoma (HCC). ...Kumamoto and Wakayama's group clearly demonstrated the following: 1) Regardless of the degree of tumor stage, a triple-positive tumor mar …
Hepatic resection (HR) and radiofrequency ablation (RFA) are popular local therapies for early-stage hepatocellular carcinoma (HCC). …
[Antihypertensive effects of amlodipine, a new calcium antagonist].
Yamanaka K, Suzuki M, Munehasu S, Ishiko J. Yamanaka K, et al. Nihon Yakurigaku Zasshi. 1991 Feb;97(2):115-26. doi: 10.1254/fpj.97.2_115. Nihon Yakurigaku Zasshi. 1991. PMID: 1829060 Japanese.
The effect of AML reached a maximum at 4-6 hr and was sustained even at 10 hr post-dose, in contrast to the case of nifedipine that produced a maximum effect at 1 hr with a rapid recovery. Heart rate (HR) was increased slowly and slightly by AML (10mg/ …
The effect of AML reached a maximum at 4-6 hr and was sustained even at 10 hr post-dose, in contrast to the case of nifedipine …
Survival impact of lymphocyte infiltration into the tumor of hepatocellular carcinoma in hepatitis B virus-positive or non-B non-C patients who underwent curative resection.
Nakagawa S, Umezaki N, Yamao T, Kaida T, Okabe H, Mima K, Imai K, Hashimoto D, Yamashita YI, Ishiko T, Chikamoto A, Baba H. Nakagawa S, et al. Hepatol Res. 2018 Feb;48(3):E126-E132. doi: 10.1111/hepr.12936. Epub 2017 Aug 10. Hepatol Res. 2018. PMID: 28696046

Multivariate analyses revealed that independent risk factors for recurrence were low albumin value (hazard ratio [HR] 2.33, P = 0.009), high American Joint Committee on Cancer (AJCC) T stage (HR 2.31, P < 0.0001), high alpha-fetoprotein (AFP) value (HR 2.0

…
Multivariate analyses revealed that independent risk factors for recurrence were low albumin value (hazard ratio [HR] 2.33, P = 0.009 …
Microvascular invasion of single small hepatocellular carcinoma ≤3 cm: Predictors and optimal treatments.
Yamashita YI, Imai K, Yusa T, Nakao Y, Kitano Y, Nakagawa S, Okabe H, Chikamoto A, Ishiko T, Yoshizumi T, Aishima S, Maehara Y, Baba H. Yamashita YI, et al. Ann Gastroenterol Surg. 2018 Jan 8;2(3):197-203. doi: 10.1002/ags3.12057. eCollection 2018 May. Ann Gastroenterol Surg. 2018. PMID: 29863190 Free PMC article.
In 428 patients with a single HCC 3 cm who had predictors for MVI, survival was compared among anatomical HR (n = 149), partial HR (n = 227), and radiofrequency ablation (RFA) (n = 52). RESULTS: The positive rate of MVI reached 40.6% (168/414 patients). ...CONCLUSIO …
In 428 patients with a single HCC 3 cm who had predictors for MVI, survival was compared among anatomical HR (n = 149), partial HR …
Impact of surgical treatment after sorafenib therapy for advanced hepatocellular carcinoma.
Takeyama H, Beppu T, Higashi T, Kaida T, Arima K, Taki K, Imai K, Nitta H, Hayashi H, Nakagawa S, Okabe H, Hashimoto D, Chikamoto A, Ishiko T, Tanaka M, Sasaki Y, Baba H. Takeyama H, et al. Surg Today. 2018 Apr;48(4):431-438. doi: 10.1007/s00595-017-1603-x. Epub 2017 Nov 7. Surg Today. 2018. PMID: 29110089

Additional surgery was the most significant factor predicting a survival exceeding 3 years (P < 0.0001) and represents an independent prognostic factor [hazard ratio (HR) 0.07; P = 0.01], followed by the total dose of sorafenib. The surgical interventions comprised two

…

Additional surgery was the most significant factor predicting a survival exceeding 3 years (P < 0.0001) and represents an independent pro

…
Endoscopic hepatic resection and endoscopic radiofrequency ablation as initial treatments for hepatocellular carcinoma within the Milan criteria.
Tsukamoto M, Imai K, Yamashita YI, Kitano Y, Okabe H, Nakagawa S, Nitta H, Chikamoto A, Ishiko T, Baba H. Tsukamoto M, et al. Surg Today. 2020 Apr;50(4):402-412. doi: 10.1007/s00595-019-01903-9. Epub 2019 Nov 3. Surg Today. 2020. PMID: 31680205
PURPOSES: The indication of endoscopic (laparoscopic and thoracoscopic) hepatic resection (HR) has been expanded in the past decade because of its low invasiveness. However, the indications of endoscopic HR and radiofrequency ablation (RFA) have not yet been determi …
PURPOSES: The indication of endoscopic (laparoscopic and thoracoscopic) hepatic resection (HR) has been expanded in the past decade b …
Clinical Significance of PD-L1 Expression in Both Cancer and Stroma Cells of Cholangiocarcinoma Patients.
Kitano Y, Yamashita YI, Nakao Y, Itoyama R, Yusa T, Umezaki N, Tsukamoto M, Yamao T, Miyata T, Nakagawa S, Okabe H, Imai K, Chikamoto A, Ishiko T, Baba H. Kitano Y, et al. Ann Surg Oncol. 2020 Feb;27(2):599-607. doi: 10.1245/s10434-019-07701-4. Epub 2019 Aug 12. Ann Surg Oncol. 2020. PMID: 31407173
The patients with positive PD-L1 expression in cancer and stroma cells had worse overall survival rates than those negative for PD-L1 (cancer cells: hazard ratio [HR] 2.08; P = 0.0004; stroma cells: HR 1.84; P = 0.003). Moreover, the patients with PD-L1-positive can …
The patients with positive PD-L1 expression in cancer and stroma cells had worse overall survival rates than those negative for PD-L1 (cance …
Comparison between hepatic resection and radiofrequency ablation as first-line treatment for solitary small-sized hepatocellular carcinoma of 3 cm or less.
Imai K, Beppu T, Chikamoto A, Doi K, Okabe H, Hayashi H, Nitta H, Ishiko T, Takamori H, Baba H. Imai K, et al. Hepatol Res. 2013 Aug;43(8):853-64. doi: 10.1111/hepr.12035. Epub 2013 Jan 2. Hepatol Res. 2013. PMID: 23281579
AIM: It is a matter of debate whether hepatic resection (HR) or radiofrequency ablation (RFA) should be preferred for the treatment of patients with hepatocellular carcinoma (HCC). The aim of this study is to compare the long-term outcome between HR and RFA in patie …
AIM: It is a matter of debate whether hepatic resection (HR) or radiofrequency ablation (RFA) should be preferred for the treatment o …
28 results